-
公开(公告)号:US12145912B2
公开(公告)日:2024-11-19
申请号:US17875982
申请日:2022-07-28
Applicant: Massachusetts Institute of Technology
Inventor: Lei Miao , Linxian Li , Daniel Griffith Anderson , Yuxuan Huang
IPC: C07D233/40 , A61K39/39 , C07C237/06 , C07C251/08 , C07D403/06 , A61K39/00
Abstract: Provided herein are lipidoid compounds of Formulae (I) and (II), and pharmaceutically acceptable salts, co-crystals, tautomers, stereoisomers, solvates, hydrates, polymorphs, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the inventive lipidoid compounds, compositions, or formulations for treating and/or preventing diseases (e.g., genetic disease, proliferative disease, hematological disease, neurological disease, painful condition, psychiatric disorder, metabolic disorder, long-term medical condition, inflammatory disease, autoinflammatory disease, liver disease, lung disease, spleen disease, familial amyloid neuropathy, cardiovascular disease, viral infection, infectious disease, fibrotic condition, or autoimmune disease) in a subject, methods for synthesizing the compounds described herein, and compounds described herein synthesized by the synthetic methods described herein. The compounds are effective carriers for the delivery of an agent such as a polynucleotide (e.g., RNA) to a cell.
-
公开(公告)号:US20230338577A1
公开(公告)日:2023-10-26
申请号:US18310891
申请日:2023-05-02
Applicant: Massachusetts Institute of Technology
Inventor: Daniel Griffith Anderson , Joseph R. Dorkin , Owen Shea Fenton , Kevin John Kauffman , Rebecca L. McClellan
IPC: A61K48/00 , C07D241/08 , A61K47/54 , A61K38/18
CPC classification number: A61K48/0033 , C07D241/08 , A61K47/545 , A61K38/1816
Abstract: Provided herein are compounds of Formula (I), and salts thereof, wherein each instance of RL is independently optionally substituted C6-C40 alkenyl. Further provided are compositions comprising a compound of Formula (I) and an agent. Further provided are methods and kits using the compositions for delivering an agent to a subject or cell and for treating and/or preventing a range of diseases. Further provided are methods of preparing compounds of Formula (I) and precursors thereof.
-
公开(公告)号:US20230257353A1
公开(公告)日:2023-08-17
申请号:US17875982
申请日:2022-07-28
Applicant: Massachusetts Institute of Technology
Inventor: Lei Miao , Linxian Li , Daniel Griffith Anderson , Yuxuan Huang
IPC: C07D233/40 , A61K39/39 , C07C237/06 , C07C251/08 , C07D403/06
CPC classification number: C07D233/40 , A61K39/39 , C07C237/06 , C07C251/08 , C07D403/06 , A61K2039/53
Abstract: Provided herein are lipidoid compounds of Formulae (I) and (II), and pharmaceutically acceptable salts, co-crystals, tautomers, stereoisomers, solvates, hydrates, polymorphs, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the inventive lipidoid compounds, compositions, or formulations for treating and/or preventing diseases (e.g., genetic disease, proliferative disease, hematological disease, neurological disease, painful condition, psychiatric disorder, metabolic disorder, long-term medical condition, inflammatory disease, autoinflammatory disease, liver disease, lung disease, spleen disease, familial amyloid neuropathy, cardiovascular disease, viral infection, infectious disease, fibrotic condition, or autoimmune disease) in a subject, methods for synthesizing the compounds described herein, and compounds described herein synthesized by the synthetic methods described herein. The compounds are effective carriers for the delivery of an agent such as a polynucleotide (e.g., RNA) to a cell.
-
公开(公告)号:US20230183168A1
公开(公告)日:2023-06-15
申请号:US18080299
申请日:2022-12-13
Applicant: Massachusetts Institute of Technology
Inventor: Daniel Griffith Anderson , Luke Hyunsik Rhym , Allen Jiang , Jacob Witten , Idris Raji
IPC: C07C237/16 , C07D211/86 , C07D211/82 , C07D207/12 , C07D207/09 , C07D231/12
CPC classification number: C07C237/16 , C07D211/86 , C07D211/82 , C07D207/12 , C07D207/09 , C07D231/12
Abstract: Provided herein are compounds, such as compounds of Formula (I), and pharmaceutically acceptable salts, hydrates, solvates, polymorphs, co-crystals, tautomers, stereoisomers, and isotopically labeled derivatives thereof, and compositions, methods, uses, and kits thereof. The compounds provided herein are lipids useful for delivery of polynucleotides, such as mRNA, for the treatment and/or prevention of various diseases and conditions (e.g., genetic disease, proliferative disease, hematological disease, neurological disease, liver disease, spleen disease, lung disease, painful condition, psychiatric disorder, musculoskeletal disease, a metabolic disorder, inflammatory disease, or autoimmune disease).
-
公开(公告)号:US11458158B2
公开(公告)日:2022-10-04
申请号:US16867291
申请日:2020-05-05
Applicant: Massachusetts Institute of Technology
Inventor: Yizhou Dong , Kevin Thomas Love , Robert S. Langer , Daniel Griffith Anderson , Delai Chen , Yi Chen , Arturo Jose Vegas , Akinleye C. Alabi , Yunlong Zhang
IPC: A61K31/7105 , C07D233/64 , C07D403/06 , C07D241/08 , C07C229/12 , C07C229/22 , C07C229/26 , C07D487/06 , C07D207/16 , C07D209/20 , C07C271/22 , C07C229/36 , C07C237/08 , C07C237/12 , C12N15/88 , C12N15/87 , C07C229/24 , C07C279/14 , C07C323/58 , C07D209/24 , C07D265/32 , C07D413/06 , C07D487/04 , C12Q1/02 , G01N33/15 , A61K31/711 , A61K47/22
Abstract: Described herein are compounds and compositions characterized, in certain embodiments, by conjugation of various groups, such as lipophilic groups, to an amino or amide group of an amino acid, a linear or cyclic peptide, a linear or cyclic polypeptide, or structural isomer thereof, to provide compounds of the present invention, collectively referred to herein as “APPLs”. Such APPLs are deemed useful for a variety of applications, such as, for example, improved nucleotide delivery. Exemplary APPLs include, but are not limited to, compounds of Formula (I), (II), (III), (IV), (V), and (VI), and salts thereof, as described herein: wherein m, n, p, R′, R1, R2, R3, R4, R5, R8, Z, W, Y, and Z are as defined herein.
-
公开(公告)号:US20210101875A1
公开(公告)日:2021-04-08
申请号:US17070486
申请日:2020-10-14
Applicant: Massachusetts Institute of Technology
Inventor: Kerry Peter Mahon , Kevin Thomas Love , Christopher G. Levins , Kathryn Ann Whitehead , Robert S. Langer , Daniel Griffith Anderson
IPC: C07D295/13 , A61K9/127 , A61K9/51 , A61K47/16 , A61K48/00 , C07C215/14 , C12N15/11 , C12N15/88 , A61K47/54 , C07C217/08 , A61K31/7088 , A61K38/02 , A61K9/107 , C12N15/113
Abstract: Aminoalcohol lipidoids are prepared by reacting an amine with an epoxide-terminated compound are described. Methods of preparing aminoalcohol lipidoids from commercially available starting materials are also provided. Aminoalcohol lipidoids may be prepared from racemic or stereochemically pure epoxides. Aminoalcohol lipidoids or salts forms thereof are preferably biodegradable and biocompatible and may be used in a variety of drug delivery systems. Given the amino moiety of these aminoalcohol lipidoid compounds, they are particularly suited for the delivery of polynucleotides. Complexes, micelles, liposomes or particles containing the inventive lipidoids and polynucleotide have been prepared. The inventive lipidoids may also be used in preparing microparticles for drug delivery. They are particularly useful in delivering labile agents given their ability to buffer the pH of their surroundings.
-
公开(公告)号:US10683379B2
公开(公告)日:2020-06-16
申请号:US15078685
申请日:2016-03-23
Applicant: Massachusetts Institute of Technology
Inventor: Daniel Griffith Anderson , Eric Andrew Appel , Yizhou Dong , Robert S. Langer , Benjamin C. Tang , Omid Veiseh , Weiheng Wang , Matthew J. Webber , Kun Xue
IPC: C08F8/12 , C08F8/28 , A61K47/32 , C08F120/56 , C08F120/60 , C08F130/06 , C08F220/56 , C08F220/60 , C08F230/06
Abstract: Described herein are polymers, polymeric gels, or a composition thereof, for drug delivery. The polymers, which include boronic-acid containing moieties (e.g., and polyol-containing moieties (e.g., are prepared by free-radical polymerization and can self-assemble into polymeric gels such as hydrogels. Also provided are methods or preparing the polymers, kits involving the polymers and/or polymeric gels or a composition thereof, for use as materials or delivery applications of an agent to a subject.
-
公开(公告)号:US20190240349A1
公开(公告)日:2019-08-08
申请号:US16268902
申请日:2019-02-06
Applicant: Massachusetts Institute of Technology
Inventor: Daniel Griffith Anderson , Joseph R. Dorkin , Owen Shea Fenton , Kevin John Kauffman , Rebecca L. McClellan
IPC: A61K48/00 , A61K47/54 , A61K38/18 , C07D241/08
Abstract: Provided herein are compounds of Formula (I), and salts thereof, wherein each instance of RL is independently optionally substituted C6-C40 alkenyl. Further provided are compositions comprising a compound of Formula (I) and an agent. Further provided are methods and kits using the compositions for delivering an agent to a subject or cell and for treating and/or preventing a range of diseases. Further provided are methods of preparing compounds of Formula (I) and precursors thereof.
-
公开(公告)号:US10201618B2
公开(公告)日:2019-02-12
申请号:US15186361
申请日:2016-06-17
Applicant: Massachusetts Institute of Technology
Inventor: Daniel Griffith Anderson , Joseph R. Dorkin , Owen Shea Fenton , Kevin John Kauffman , Rebecca L. McClellan
Abstract: Provided herein are compounds of Formula (I), and salts thereof, wherein each instance of RL is independently optionally substituted C6-C40 alkenyl. Further provided are compositions comprising a compound of Formula (I) and an agent. Further provided are methods and kits using the compositions for delivering an agent to a subject or cell and for treating and/or preventing a range of diseases. Further provided are methods of preparing compounds of Formula (I) and precursors thereof.
-
公开(公告)号:US20180296733A1
公开(公告)日:2018-10-18
申请号:US15988753
申请日:2018-05-24
Inventor: Paul Williams , Morgan Russell Alexander , Martyn Christopher Davies , Robert Langer , Daniel Griffith Anderson
IPC: A61L29/16
Abstract: The invention provides a method for inhibiting bacterial attachment to a surface, the method comprising forming the surface from a polymer, or applying a polymer to the surface, wherein the polymer is a homopolymer formed from a (meth) acrylate or (meth) acrylamide monomer or a copolymer formed from one or more (meth) acrylate or (meth) acrylamide monomers, wherein the (meth) acrylate or (meth) acrylamide monomers are of formula (I) or (II): [H2C═CR′—C(=0)-0-]n, R (I) [H2C═CR′—C(=0)-NH—]n R (II) wherein n is 1, 2 or 3, R′ is independently H or CH3, R is an organic group having a total of from 2 to 24 carbon atoms, wherein the organic group includes an aliphatic or aromatic hydrocarbon moiety and wherein the organic group does not include any hydroxyl groups.
-
-
-
-
-
-
-
-
-